Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Short Bowel Syndrome market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Short Bowel Syndrome market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Short Bowel Syndrome market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Short Bowel Syndrome products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Short Bowel Syndrome products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Short Bowel Syndrome market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Short Bowel Syndrome development has been the leading industry trend of Short Bowel Syndrome market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Short Bowel Syndrome Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
GLP-2, Growth Hormone, Glutamine, Others |
| By Application Outlook |
Hospitals, Clinics, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Shire, Merck, Emmaus Life Sciences, Nutrinia, GlyPharma Therapeutics, OxThera, Ardelyx, Sancilio & Company, Naia Pharmaceuticals, Zealand Pharma |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Shire
- Merck
- Emmaus Life Sciences
- Nutrinia
- GlyPharma Therapeutics
- OxThera
- Ardelyx
- Sancilio & Company
- Naia Pharmaceuticals
- Zealand Pharma
Short Bowel Syndrome Market, By Type
- GLP-2
- Growth Hormone
- Glutamine
- Others
Short Bowel Syndrome Market, By Application
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Short Bowel Syndrome Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Short Bowel Syndrome Market Size Growth Rate by Product
1.4.2 GLP-2
1.4.3 Growth Hormone
1.4.4 Glutamine
1.4.5 Others
1.5 Market by End User
1.5.1 Global Short Bowel Syndrome Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Clinics
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Short Bowel Syndrome Market Size
2.1.1 Global Short Bowel Syndrome Revenue 2017-2027
2.1.2 Global Short Bowel Syndrome Sales 2017-2027
2.2 Short Bowel Syndrome Growth Rate by Regions
2.2.1 Global Short Bowel Syndrome Sales by Regions
2.2.2 Global Short Bowel Syndrome Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Short Bowel Syndrome Sales by Manufacturers
3.1.1 Short Bowel Syndrome Sales by Manufacturers
3.1.2 Short Bowel Syndrome Sales Market Share by Manufacturers
3.1.3 Global Short Bowel Syndrome Market Concentration Ratio (CR5 and HHI)
3.2 Short Bowel Syndrome Revenue by Manufacturers
3.2.1 Short Bowel Syndrome Revenue by Manufacturers (2017-2020)
3.2.2 Short Bowel Syndrome Revenue Share by Manufacturers (2017-2020)
3.3 Short Bowel Syndrome Price by Manufacturers
3.4 Short Bowel Syndrome Manufacturing Base Distribution, Product Types
3.4.1 Short Bowel Syndrome Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Short Bowel Syndrome Product Type
3.4.3 Date of International Manufacturers Enter into Short Bowel Syndrome Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Short Bowel Syndrome Sales by Product
4.2 Global Short Bowel Syndrome Revenue by Product
4.3 Short Bowel Syndrome Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Short Bowel Syndrome Breakdown Data by End User
6 North America
6.1 North America Short Bowel Syndrome by Countries
6.1.1 North America Short Bowel Syndrome Sales by Countries
6.1.2 North America Short Bowel Syndrome Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Short Bowel Syndrome by Product
6.3 North America Short Bowel Syndrome by End User
7 Europe
7.1 Europe Short Bowel Syndrome by Countries
7.1.1 Europe Short Bowel Syndrome Sales by Countries
7.1.2 Europe Short Bowel Syndrome Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Short Bowel Syndrome by Product
7.3 Europe Short Bowel Syndrome by End User
8 Asia Pacific
8.1 Asia Pacific Short Bowel Syndrome by Countries
8.1.1 Asia Pacific Short Bowel Syndrome Sales by Countries
8.1.2 Asia Pacific Short Bowel Syndrome Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Short Bowel Syndrome by Product
8.3 Asia Pacific Short Bowel Syndrome by End User
9 Central & South America
9.1 Central & South America Short Bowel Syndrome by Countries
9.1.1 Central & South America Short Bowel Syndrome Sales by Countries
9.1.2 Central & South America Short Bowel Syndrome Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Short Bowel Syndrome by Product
9.3 Central & South America Short Bowel Syndrome by End User
10 Middle East and Africa
10.1 Middle East and Africa Short Bowel Syndrome by Countries
10.1.1 Middle East and Africa Short Bowel Syndrome Sales by Countries
10.1.2 Middle East and Africa Short Bowel Syndrome Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Short Bowel Syndrome by Product
10.3 Middle East and Africa Short Bowel Syndrome by End User
11 Company Profiles
11.1 Shire
11.1.1 Shire Company Details
11.1.2 Company Business Overview
11.1.3 Shire Short Bowel Syndrome Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Shire Short Bowel Syndrome Products Offered
11.1.5 Shire Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Company Business Overview
11.2.3 Merck Short Bowel Syndrome Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Merck Short Bowel Syndrome Products Offered
11.2.5 Merck Recent Development
11.3 Emmaus Life Sciences
11.3.1 Emmaus Life Sciences Company Details
11.3.2 Company Business Overview
11.3.3 Emmaus Life Sciences Short Bowel Syndrome Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Emmaus Life Sciences Short Bowel Syndrome Products Offered
11.3.5 Emmaus Life Sciences Recent Development
11.4 Nutrinia
11.4.1 Nutrinia Company Details
11.4.2 Company Business Overview
11.4.3 Nutrinia Short Bowel Syndrome Sales, Revenue and Gross Margin (2017-2020)
11.4.4 Nutrinia Short Bowel Syndrome Products Offered
11.4.5 Nutrinia Recent Development
11.5 GlyPharma Therapeutics
11.5.1 GlyPharma Therapeutics Company Details
11.5.2 Company Business Overview
11.5.3 GlyPharma Therapeutics Short Bowel Syndrome Sales, Revenue and Gross Margin (2017-2020)
11.5.4 GlyPharma Therapeutics Short Bowel Syndrome Products Offered
11.5.5 GlyPharma Therapeutics Recent Development
11.6 OxThera
11.6.1 OxThera Company Details
11.6.2 Company Business Overview
11.6.3 OxThera Short Bowel Syndrome Sales, Revenue and Gross Margin (2017-2020)
11.6.4 OxThera Short Bowel Syndrome Products Offered
11.6.5 OxThera Recent Development
11.7 Ardelyx
11.7.1 Ardelyx Company Details
11.7.2 Company Business Overview
11.7.3 Ardelyx Short Bowel Syndrome Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Ardelyx Short Bowel Syndrome Products Offered
11.7.5 Ardelyx Recent Development
11.8 Sancilio & Company
11.8.1 Sancilio & Company Company Details
11.8.2 Company Business Overview
11.8.3 Sancilio & Company Short Bowel Syndrome Sales, Revenue and Gross Margin (2017-2020)
11.8.4 Sancilio & Company Short Bowel Syndrome Products Offered
11.8.5 Sancilio & Company Recent Development
11.9 Naia Pharmaceuticals
11.9.1 Naia Pharmaceuticals Company Details
11.9.2 Company Business Overview
11.9.3 Naia Pharmaceuticals Short Bowel Syndrome Sales, Revenue and Gross Margin (2017-2020)
11.9.4 Naia Pharmaceuticals Short Bowel Syndrome Products Offered
11.9.5 Naia Pharmaceuticals Recent Development
11.10 Zealand Pharma
11.10.1 Zealand Pharma Company Details
11.10.2 Company Business Overview
11.10.3 Zealand Pharma Short Bowel Syndrome Sales, Revenue and Gross Margin (2017-2020)
11.10.4 Zealand Pharma Short Bowel Syndrome Products Offered
11.10.5 Zealand Pharma Recent Development
12 Future Forecast
12.1 Short Bowel Syndrome Market Forecast by Regions
12.1.1 Global Short Bowel Syndrome Sales Forecast by Regions 2021-2027
12.1.2 Global Short Bowel Syndrome Revenue Forecast by Regions 2021-2027
12.2 Short Bowel Syndrome Market Forecast by Product
12.2.1 Global Short Bowel Syndrome Sales Forecast by Product 2021-2027
12.2.2 Global Short Bowel Syndrome Revenue Forecast by Product 2021-2027
12.3 Short Bowel Syndrome Market Forecast by End User
12.4 North America Short Bowel Syndrome Forecast
12.5 Europe Short Bowel Syndrome Forecast
12.6 Asia Pacific Short Bowel Syndrome Forecast
12.7 Central & South America Short Bowel Syndrome Forecast
12.8 Middle East and Africa Short Bowel Syndrome Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Short Bowel Syndrome Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
